Detalhe da pesquisa
1.
Impact of pre-analytical sample handling factors on plasma biomarkers of Alzheimer's disease.
J Neurochem
; 165(1): 95-105, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36625424
2.
The potential clinical value of plasma biomarkers in Alzheimer's disease.
Alzheimers Dement
; 19(12): 5805-5816, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694991
3.
Clinical performance and robustness evaluation of plasma amyloid-ß42/40 prescreening.
Alzheimers Dement
; 19(4): 1393-1402, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150024
4.
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
Alzheimers Dement
; 19(4): 1204-1215, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950735
5.
Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models.
Alzheimers Dement
; 2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699240
6.
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.
Blood
; 131(25): 2789-2802, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653964
7.
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib.
Blood
; 127(23): 2847-55, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26941398
8.
MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
Br J Haematol
; 179(3): 421-429, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28771672
9.
Optimized Pre-analytical Handling Protocol for Blood-Based Biomarkers of Alzheimer's Disease.
Methods Mol Biol
; 2785: 67-73, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38427188
10.
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.
Br J Haematol
; 163(4): 496-500, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24032483
11.
Diagnostic performance of automated plasma amyloid-ß assays combined with pre-analytical immunoprecipitation.
Alzheimers Res Ther
; 14(1): 127, 2022 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071505
12.
Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies.
Leukemia
; 34(11): 2934-2950, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404973
13.
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.
Cancer Res
; 79(12): 3125-3138, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31000522
14.
Drug-perturbation-based stratification of blood cancer.
J Clin Invest
; 128(1): 427-445, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29227286
15.
Next-generation sequencing of cancer consensus genes in lymphoma.
Leuk Lymphoma
; 54(8): 1831-5, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23621802
16.
Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.
Leuk Lymphoma
; 53(6): 1023-31, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22023519
17.
Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.
J Clin Oncol
; 31(19): e300-3, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23690412